Clinical heterogeneity in Progressive Supranuclear Palsy: Challenges to diagnosis, pathogenesis and future therapies-Reference-Cited by-同舟云学术

Clinical heterogeneity in Progressive Supranuclear Palsy: Challenges to diagnosis, pathogenesis and future therapies

Published:2014-11-10 Issue:14 Volume:29 Page:1707-1709
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Lang Anthony E.¹

Affiliation:

1. Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference20 articles.

1. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of "heterogenous system degeneration";Richardson;Trans Am Neurol Assoc,1963

2. Progressive supranuclear palsy;Steele;Arch Neurol,1964

3. Progressive supranuclear palsy;Steele;Brain,1972

4. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges;Williams;Lancet Neurol,2009

5. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia;Kanazawa;Parkinsonism Relat Disord,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinsonism and Digital Measurement;Studies in Neuroscience, Psychology and Behavioral Economics;2022-07-23

2. Protracted course progressive supranuclear palsy;European Journal of Neurology;2022-04-21

3. Involuntary Movement Disorders;Kaufman's Clinical Neurology for Psychiatrists;2022

4. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale;Neurodegenerative Diseases;2020

5. Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly;Revista Española de Geriatría y Gerontología;2019-09